1-3 of 3
Anant Vatsayan
Close
Sort by
Journal Articles

Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas

Clinical Trials & Observations
Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Anant Vatsayan, Julie-An Talano, Christina Baggott, Deborah E Schiff, Emmanuel Katsanis, Arunkumar Modi, Troy C Quigg, Sunil S Raikar, Liora M. Schultz, Lauren Pommert
Journal: Blood Advances
Blood Adv bloodadvances.2024012928.
https://doi.org/10.1182/bloodadvances.2024012928
Published: 2024
Includes: Supplemental data
Journal Articles

HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL

Clinical Trials & Observations
Kevin O. McNerney, Stephanie J. Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, John J. Chen, Christina Baggott, Snehit Prabhu, Holly L. Pacenta, Christine Philips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Michael Verneris, Doug Myers, Nicole A. Karras, Patrick Brown, Challice L. Bonifant, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Susanne H. C. Baumeister, Vanessa A. Fabrizio, Vasant Chinnabhandar, Emily Egeler, Sharon Mavroukakis, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2758–2771.
https://doi.org/10.1182/bloodadvances.2022008893
Published: 2023
Includes: Supplemental data
Journal Articles

Anakinra utilization in refractory pediatric CAR T-cell associated toxicities

Caroline Diorio, Anant Vatsayan, Aimee C. Talleur, Colleen Annesley, Jennifer J. Jaroscak, Haneen Shalabi, Amanda K. Ombrello, Michelle Hudspeth, Shannon L. Maude, Rebecca A. Gardner, Nirali N. Shah
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3398–3403.
https://doi.org/10.1182/bloodadvances.2022006983
Published: 2022
Includes: Supplemental data